New research from investigators at the Mayo Clinic has determined that vitamin D supplementation may alter immune responses to the gut microbiome in people with inflammatory bowel disease (IBD), altering antibody activity that can reduce inflammation. The study, published in Cell Reports Medicine, showed that vitamin D supplementation appears to shift the immune system toward a more balanced and protective response to gut bacteria by increasing IgA-linked defenses and reducing IgG-associated inflammation.
“This study suggests vitamin D may help rebalance how the immune system sees gut bacteria,” said lead author John Mark Gubatan, MD, an assistant professor of medicine in the division of gastroenterology and hepatology at Mayo Clinic in Jacksonville, FL. “That’s an important step toward understanding how we might restore immune tolerance in IBD.” He added that while the findings point to potential therapeutic strategies, they require confirmation in larger, controlled trials.
IBD, which includes Crohn’s disease and ulcerative colitis, is a chronic inflammatory disorder of the gastrointestinal tract that affects millions of people worldwide. It arises from interactions between genetic predisposition and environmental triggers, with loss of immune tolerance to commensal gut bacteria playing a central role in disease development and symptoms. Current therapies such as corticosteroids, immunosuppressants, and others target inflammation, but do not directly address disruptions in immune-microbiome interactions.
Prior research had suggested a link between vitamin D and both immune regulation and gut microbiome composition. These studies have shown that vitamin D influences B and T cell function, reduces IgG secretion, and promotes regulatory T cell differentiation. Vitamin D has also been associated with increased diversity of gut bacteria. Based on this, the Mayo Clinic team hypothesized that vitamin D could regulate how antibodies bind to gut microbes, potentially influencing immune tolerance.
For their research, the Mayo team conducted an interventional study that enrolled 48 patients with IBD and low levels of vitamin D. Participants received weekly vitamin D supplementation for 12 weeks. The team used multi-omics approaches, including IgA-seq and IgG-seq, single-cell RNA sequencing, and immune repertoire sequencing, the researcher analyzed blood and stool samples collected before and after treatment to compare the any differences.
Data analysis of before and after vitamin D supplementation showed that vitamin D altered antibody binding patterns to gut bacteria and reshaped immune cell populations, including increases in α4β7+ B and T regulatory cells involved in controlling inflammation. These data indicated that vitamin D promotes a shift toward protective IgA-mediated responses while reducing the inflammation caused by IgG.
The authors emphasized that vitamin D helped increase IgA binding to gut bacteria promoting intestinal homeostasis, noting that IgA-bound bacteria can contribute to mucus production, barrier integrity, and production of short-chain fatty acids and secondary bile acids with anti-inflammatory properties. At the same time, reducing IgG binding to proinflammatory bacteria could quell activation of the inflammatory pathways linked to IBD progression.
The investigators noted that their findings could provide future basis for employing vitamin D supplements as method to restore immune balance in people with IBD, a potentially new method compared with current strategies aimed at treating the inflammation itself.
While the results are promising, the researchers pointed out that their study was not a randomized study and involved a small cohort of patients. Because of this, there is a need for future studies to enroll a much larger number of patients to determine causality, optimal dosing, and long-term effects. Additional avenues for future research include how vitamin D influences microbiome components beyond bacteria, such as viruses and fungi, and whether similar immune modulating effects can be achieved through diet or even sunlight exposure.
